SCHEMBL1836155

SCHEMBL1836155

NC(=O)CNc1nc2ccc(Sc3cnc4ncccn34)cc2s1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PCSK9 Q8NBP7 7/20 0.37
PKM P14618 3/20 0.36
MAPT P10636 6/20 0.36
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36
OPRK1 P41145 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
HTT P42858 2/20 0.36
POLB P06746 1/20 0.36
AGTR1 P30556 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
KMT2A Q03164 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
PIK3CA P42336 5/20 0.35
MEN1 O00255 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
GAA P10253 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2547154 0.99 PCSK9 (0.36) PCSK9PKMMAPTNPC1RAB9A
SCHEMBL1836150 0.85 MAPT (0.42) PKMMAPTNPC1RAB9AOPRK1
Hydrochloric Acid SCHEMBL2547151 0.84 MAPT (0.42) PKMMAPTNPC1RAB9AOPRK1
SCHEMBL2538170 0.84 PIK3CA (0.49) NPC1RAB9ASMN1; SMN2HTTPIK3CA
SCHEMBL1829720 0.83 RAB9A (0.48) MAPTNPC1RAB9ASMN1; SMN2HTT
SCHEMBL1828695 0.83 MAPT (0.42) PKMMAPTNPC1RAB9AOPRK1
SCHEMBL2540705 0.83 RAB9A (0.42) PKMMAPTNPC1RAB9AOPRK1
SCHEMBL1841257 0.81 CASP3 (0.50) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL2547101 0.81 LRRK2 (0.52) PKMMAPTNPC1RAB9AOPRK1
SCHEMBL2547102 0.80 NPC1 (0.46) PKMMAPTNPC1RAB9AOPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2318414-A2 IMIDAZO [1,2-A] PYRIMIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, USE AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND USE AS MET INHIBITORS Sanofi-Aventis (FR) 2011-05-11 EP disclosed
WO-2010007318-A2 NOVEL IMIDAZO[1,2-A]PYRIMIDINE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, USE THEREOF AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE IN PARTICULAR AS MET INHIBITORS SANOFI-AVENTIS (FR) 2010-01-21 WO disclosed